ClinicalTrials.Veeva

Menu

QuitAdvisorDDS: A Point-of-Care Tobacco Cessation Tool for Dental Settings (QA-DDS)

J

Jamie Studts

Status

Completed

Conditions

Tobacco Use

Treatments

Behavioral: QA-DDS

Study type

Interventional

Funder types

Other
NETWORK
NIH

Identifiers

NCT02570646
10-155-E
R44DE021327 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Using a single-arm trial design, this study will examine the feasibility and acceptability of evaluating QuitAdvisorDDS, a clinical decision support software application designed to facilitate implementation of evidence-based tobacco treatment interventions into the dental setting. The study will examine the feasibility and acceptability of evaluating the impact of the QuitAdvisorDDS tool on patient outcomes related to tobacco use and cessation attempts as well as provider knowledge, attitudes, and practices regarding tobacco treatment. Practitioners (dentists and hygienists) will complete surveys at baseline and follow-up, while patients will complete surveys at baseline and 1-month follow-up. An embedded substudy will also evaluate the feasibility and acceptability of collecting biospecimens (saliva) to serve as biochemical verification of smoking status.

Enrollment

248 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Receives dental care from a participating practitioner;
  • Is age 18 or older;
  • Self-reports tobacco use within the past month;
  • Willing to comply with all study procedures and be available for the duration of the study;
  • Willing to provide verbal informed consent;
  • Has access to a telephone, and agrees to receive text messages, emails, or telephone calls related to the study. (The patient's preferred method of contact will be ascertained).
  • Willing to be contacted on a regular basis by each of these entities: the practice;Regional Coordinators (RC) and/or University of Kentucky (UK) researchers; and
  • Willing to provide contact information of one person living at a different address who will know the patient's whereabouts in the event the patient cannot be reached.

Exclusion criteria

  • Psychiatric disability or mental illness judged by the practitioner to be clinically significant so as to preclude informed consent or compliance with procedures of study visits.
  • Cognitive impairment judged by the practitioner to be significant so as to preclude informed consent or compliance with procedures of study visits.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

248 participants in 1 patient group

QA-DDS
Experimental group
Description:
Patients will receive exposure to the QA-DDS tool from their dental care practitioner.
Treatment:
Behavioral: QA-DDS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems